Polarean Imaging Expands FDA Clearance for MRI Technology

Polarean Imaging (GB:POLX) has released an update.

Polarean Imaging has secured FDA clearance for its XENOVIEW® 3T Chest Coil to be used with GE HealthCare’s 3 Tesla MRI systems, expanding accessibility for Xenon MRI lung function scanning across all major MRI platforms. This approval allows more institutions to adopt Polarean’s innovative imaging technology, enhancing capabilities in detecting and monitoring lung diseases. The move signifies a major step in broadening the reach of Polarean’s advanced diagnostic solutions in the healthcare market.

For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.